Price
$1.00
Increased by +12.07%
Dollar volume (20D)
34.29 K
ADR%
6.29
Shares float
3.65 M
Shares short
2.81 K [0.08%]
Shares outstanding
3.79 M
Market cap
3.38 M
Beta
-0.01
Price/earnings
N/A
20D range
0.80 1.03
50D range
0.80 1.19
200D range
0.80 2.51

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy.

It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance.

The company is based in Calgary, Canada.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 14, 25 0.04
Decreased by -97.04%
-
Mar 31, 25 -0.81
Decreased by -26.70%
-0.41
Decreased by -94.17%
Nov 12, 24 -0.20
Increased by +69.82%
-
Aug 14, 24 0.06
Increased by +107.33%
-0.92
Increased by +106.35%
May 15, 24 1.35
Increased by +1.33 K%
-0.28
Increased by +588.04%
Dec 31, 23 -0.64
Decreased by -218.00%
-0.81
Increased by +21.96%
Nov 14, 23 -0.67
Decreased by -292.27%
-0.19
Decreased by -252.63%
Aug 14, 23 -0.80
Decreased by -566.67%
-1.36
Increased by +41.18%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by N/A%
-698.67 K
Increased by +76.86%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 0.00
Decreased by N/A%
119.08 K
Decreased by -95.59%
Increased by +N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-587.01 K
Increased by +55.98%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
170.07 K
Increased by +110.05%
Increased by +N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-3.02 M
Decreased by -64.79%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
2.70 M
Increased by +192.50%
Increased by +N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-1.33 M
Increased by +14.66%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-1.69 M
Decreased by -6.99%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY